An outbreak of group A streptococcal infection

Abstract

Group A streptococcal (GAS) infection is responsible for a wide range of infections including sore G throat, skin infections, septicaemia, streptococcal toxic shock syndrome and necrotising fasciitis.

During April 2010, three patients on a medical ward in a small acute hospital in the United Kingdom had GAS identified in samples obtained from a blood culture and various lesions.

The investigation and management of this outbreak included effective antimicrobial management and treatment of identified cases, establishment of an outbreak control team (OCT), epidemiological investigation and screening of staff for throat carriage and staff and patients on the ward for skin lesions and dermatitis. Isolate typing by the Health Protection Agency (HPA), Centre for Infections laboratory, confirmed the three cases had identical strains — type M/emm44. The prompt treatment and effective management of the outbreak ensured that no further cases in the extended surveillance period were identified.

Keywords

Group A Streptococci streptococcus pyogenes outbreak

Get full access to this article

View all access options for this article.

References

Beall B. , Facklam R. , Thompson T. ( 1996) Sequencing emm-specific PCR products for routine and accurate typing of group A Streptococci. Journal of Clinical Microbiology 34(4): 953-8.

Daneman N. , Green KA , Low DE , Simor AE , Willey B. , Schwartz B. , Toye B. , Jessamine P. , Tyrrell GJ , Krajden S. , Ramage L. , Rose D. , Schertzberg R. , Bragg D. , McGeer A. and the Ontario Group A Streptococcal Study Group ( 2007) Surveillance for hospital outbreaks of invasive group A Streptococcal infections in Ontario, Canada, 1992 to 2000. Annals of Internal Medicine 147: 234-41.

Department of Health (2006) Environment and sustainability. Healthcare Technical Memorandum 07-01: Safe management of healthcare waste. DH: Leeds .

F ischetti VA ( 1989) Streptococcal M protein: molecular design and biological behaviour. Clinical Microbiology Reviews 2(3): 285-314.

Gillespie S. , Bamford K. ( 2007) Medical Microbiology and Infection at a Glance (3rd edn). Blackwell Publishing : Oxford.

Griffith CJ , Cooper RA , Gilmore J. , Davies C. , Lewis M. ( 2000) An evaluation of hospital cleaning regimes and standards . Journal of Hospital Infection 45: 19-28.

Health Protection Agency/Group A Streptococcus Working Group (2004) Interim UK guidelines for management of close community contacts of invasive group A Streptococcal disease. Communicable Disease and Public Health 7(4): 354-61.

Health Protection Agency (HPA) (2008) Interim UK guidelines for management of close community contacts of invasive group A streptococcal (iGAS). March. http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1229673231242 (accessed 10 May 2010).

CNA (2004) Audit tools for monitoring infection control standards. ICNA: London.

10.

Lamagni TL , Neal S. , Keshishian C. , Alhaddad N. , George R. , Duckworth G. , Vuopio-Varkila J. , Efstratiou A. ( 2008a) Severe Streptococcus pyogenes Infections, United Kingdom, 2003-2004. Emerging Infectious Diseases 14(2): 201-9.

11.

Lamagni TL , Darenberg J. , Luca-Harari B. , Siljander T. , Efstratiou A. , Henriques-Normark B. , Vuopio-Varkila J. , Bouvet A. , Creti R. , Ekelund K. , Koliou M. , Rene-Reinert R. , Stathi A. , Strakova L. , Ungureanu V. , Schalén C. , the Strep-EURO Study Group , Jasir A. (2008b) Epidemiology of severe Streptococcus pyogenes disease in Europe. Journal of Clinical Microbiology 46(7): 2359-67.

12.

Luca-Harari B. , Darenberg J. , Neal S. , Siljander T. , Strakova L. , Tanna A. , Creti R. , Ekelund K. , Koliou M. , Tassios PT , Van der Linden M. , Straut M. , Vuopio-Varkila J. , Bouvet A. , Efstratiou A. , Schalén C. , Henriques-Normark B. , the Strep-EURO Study Group , Jasir A. (2009) Clinical and microbiological characteristics of severe Stretococcus pyogenes disease in Europe. Journal of Clinical Microbiology 47(4): 1155-65.

13.

Moses AE , Wessels MR , Zalcman K. , Alberti S. , Natanson-Yaron S. , Menes T. , Hanski E. ( 1997) Relative contributions of hyaluronic acid capsule and M protein to virulence in a mucoid strain of the Group a Streptococcus . Infection and Immunity 65(1): 64-71.

14.

Public Health Agency of Canada (2006) Guidelines for the prevention and control of invasive group A Streptococcal disease. Canada Communicable Disease Report 32S2: 1-26.

15.

Sherertz RJ , Bassetti S. , Bassetti-Wyss B. ( 2001) ‘Cloud’ healthcare workers. Emerging Infectious Diseases 7(2): 241-4.

16.

Sherlock O. , O’Connel N. , Creamer E. , Humphreys H. ( 2009) Is it really clean? An evaluation of the efficacy of four methods for determining hospital cleanliness. Journal of Hospital Infection 72(2): 140-6.

17.

Steer AC , Law I. , Matatolu L. , Beall BW , Carapetis JR. (2009) Global emm type distribution of Group A Streptococci: systematic review and implications for vaccine development. Lancet Infectious Diseases 9(10): 611-16.

18.

World Health Organization / Patient Safety and World Alliance for Safer Care (2009) WHO guidelines on hand hygiene in healthcare; first global patient safety challenge. Clean care is safer care. WHO: Switzerland.